Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment

OBJECTIVE: The objective of the study was to assess the tolerability and safety of galcanezumab in patients with chronic cluster headache (CH) with up to 15 months of treatment. BACKGROUND: Chronic CH is a highly debilitating disease with a substantial and unmet medical need. METHODS: Patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Láinez, Miguel J. A., Schoenen, Jean, Stroud, Chad, Bardos, Jennifer, Bangs, Mark, Kemmer, Phebe, Wenzel, Richard, Kuruppu, Dulanji K., Martinez, James Michael, Oakes, Tina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299588/
https://www.ncbi.nlm.nih.gov/pubmed/34806783
http://dx.doi.org/10.1111/head.14234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299588/
https://www.ncbi.nlm.nih.gov/pubmed/34806783
http://dx.doi.org/10.1111/head.14234

Ejemplares similares